Drug Discovery Informatics Market
PUBLISHED: 2021 ID: SMRC20612
SHARE
SHARE

Drug Discovery Informatics Market

Drug Discovery Informatics Market Forecasts to 2028 – Global Analysis By Solution (Software, Services), Application (Drug Discovery, Drug Development), End User (Biotechnology Companies, Hospital) and By Geography

4.6 (17 reviews)
4.6 (17 reviews)
Published: 2021 ID: SMRC20612

This report covers the impact of COVID-19 on this global market
Loading...

According to Stratistics MRC, the Global Drug Discovery Informatics market is accounted for $2.24 billion in 2020 and is expected to reach $5.27 billion by 2028 growing at a CAGR of 11.3% during the forecast period. Rising research & development (R&D) expenditure, growing support for research, especially in the area of rare diseases, and the increasing use of informatics in drug discovery are the major factors driving the market growth. However, the scarcity of skilled professionals is restraining the market growth.

Drug Discovery Informatics enables users to address large volume of data storage & management and further processing & analyzing the obtained results. Drug discovery informatics platforms utilize bioinformatics algorithms for processing life science data and uses various in silico models for analyzing the data obtained.

Based on function, the sequencing and target data analysis segment is estimated to have a lucrative growth due to increased application for sequencing analysis for the new drug entity and ease of handling of information from different domains and sources. By geography, North America is going to have high growth during forecast period due to the large share in the global market can be attributed to the presence of well-established contract research organization (CROs), rising R&D expenditure by pharmaceutical and biopharmaceutical companies.

Some of the key players profiled in the Drug Discovery Informatics Market include Albany Molecular Research Inc., Certara, L.P., Charles River, Selvita, Collaborative Drug Discovery, Inc, Dassault Systèmes, GVK Biosciences Private Limited, IBM Corporation, Infosys Limited, Insilico Medicine, IO Informatics, Inc., Jubilant Life Sciences Ltd., OpenEye Scientific Software, PerkinElmer Inc., Schrödinger, LLC and Thermo Fisher Scientific.

Report Coverage

Details

Published Year:

2021

Estimated Market Size in 2020:

USD 2.24billion

Estimated Period:

2020

Compound Annual Growth Rate (CAGR) from 2020 to 2028:

11.3%

Predicted 2028 Value:

USD 5.27billion

Forecast Years:

2021-2028

Tables, Graphs & Figures

302

Chapters Covered:

Type, Solution, Function, Informatics Workflow, Modality, Application, End User and Region

Core Drivers and Opportunities:

  • Rising research & development (R&D) expenditure
  • Increasing use of informatics in drug discovery
  • Growing support for research

Restraining Factors & Market Threats:

  • Scarcity of skilled professionals
  • High setup costs of informatics software


Types Covered:
• In-House
• Outsourced

Solutions Covered:
• Software
• Services

Functions Covered:
• Clinical Trial Data Management
• Docking
• Library & Database Preparation
• Molecular Modelling
• Screening & Absorption, Distribution, Metabolism, Excretion and Toxicity (ADMET) Characterization
• Sequencing and Target Data Analysis

Informatics Workflows Covered:
• Discovery Informatics
• Development Informatics

Modalities Covered:
• Cloud Based Systems
• In Campus Platform

Applications Covered:
• Drug Discovery
• Drug Development

End Users Covered:
• Academic Institutes
• Biotechnology Companies
• Contract Research Organization (CROs)
• Government Organizations
• Hospital
• Pharmaceutical Companies
• University

Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o UK
o Italy
o France
o Spain
o Rest of Europe
• Asia Pacific
o Japan       
o China       
o India       
o Australia 
o New Zealand
o South Korea
o Rest of Asia Pacific    
• South America
o Argentina
o Brazil
o Chile
o Rest of South America
• Middle East & Africa
o Saudi Arabia
o UAE
o Qatar
o South Africa
o Rest of Middle East & Africa

What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2019, 2020, 2021, 2025, and 2028
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements

Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT Analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
o Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Key Questions Answered In The Report

The Global Drug Discovery Informatics Market is majorly driven by rising research & development (R&D) expenditure, growing support for research, especially in the area of rare diseases, and the increasing use of informatics in drug discovery.

The sequencing and target data analysis segment is growing at a highest CAGR owing to increased application for sequencing analysis for the new drug entity and ease of handling of information from different sources and different domains.

North America dominated with a significant market share due to the factors such as presence of well-established CROs, rising R&D expenditure by pharmaceutical and biopharmaceutical companies in the region.

Asia Pacific market is growing at a highest CAGR owing to the rapid growth in the pharmaceutical and biopharmaceutical industry, rising number of CROs, and the presence of less-stringent regulations for drug discovery processes.

Key players in Drug Discovery Informatics Market include Albany Molecular Research Inc., Certara, L.P., Charles River, Selvita, Collaborative Drug Discovery, Inc, Dassault Systèmes, GVK Biosciences Private Limited, IBM Corporation, Infosys Limited, Insilico Medicine, IO Informatics, Inc., Jubilant Life Sciences Ltd., OpenEye Scientific Software, PerkinElmer Inc., Schrödinger, LLC and Thermo Fisher Scientific.

Table of Contents

1 Executive Summary     
      
2 Preface     

 2.1 Abstract    
 2.2 Stake Holders    
 2.3 Research Scope    
 2.4 Research Methodology    
  2.4.1 Data Mining   
  2.4.2 Data Analysis   
  2.4.3 Data Validation   
  2.4.4 Research Approach   
 2.5 Research Sources    
  2.5.1 Primary Research Sources   
  2.5.2 Secondary Research Sources   
  2.5.3 Assumptions   
      
3 Market Trend Analysis     
 3.1 Introduction    
 3.2 Drivers    
 3.3 Restraints    
 3.4 Opportunities    
 3.5 Threats    
 3.6 Application Analysis    
 3.7 End User Analysis    
 3.8 Emerging Markets    
 3.9 Impact of Covid-19    
      
4 Porters Five Force Analysis     
 4.1 Bargaining power of suppliers    
 4.2 Bargaining power of buyers    
 4.3 Threat of substitutes    
 4.4 Threat of new entrants    
 4.5 Competitive rivalry    
      
5 Global Drug Discovery Informatics Market, By Type     
 5.1 Introduction     
 5.2 In-House    
 5.3 Outsourced    
      
6 Global Drug Discovery Informatics Market, By Solution     
 6.1 Introduction    
 6.2 Software    
 6.3 Services    
      
7 Global Drug Discovery Informatics Market, By Function     

 7.1 Introduction    
 7.2 Clinical Trial Data Management    
 7.3 Docking    
 7.4 Library & Database Preparation    
 7.5 Molecular Modelling    
 7.6 Screening & Absorption, Distribution, Metabolism, Excretion and Toxicity (ADMET) Characterization    
 7.7 Sequencing and Target Data Analysis    
      
8 Global Drug Discovery Informatics Market, By Informatics Workflow     
 8.1 Introduction    
 8.2 Discovery Informatics    
  8.2.1 Identification, Validation, & Assay Development Informatics   
  8.2.2 Lead Generation & Validation   
 8.3 Development Informatics    
  8.3.1 Lead Optimization   
  8.3.2 First Human Dose (FHD) Preparation   
  8.3.3 Phase IA Informatics   
  8.3.4 Phase IB/2 Informatics   
      
9 Global Drug Discovery Informatics Market, By Modality     
 9.1 Introduction    
 9.2 Cloud Based Systems    
 9.3 In Campus Platform    
      
10 Global Drug Discovery Informatics Market, By Application     
 10.1 Introduction    
 10.2 Drug Discovery    
  10.2.1 Preclinical Testing   
  10.2.2 Clinical Trials   
 10.3 Drug Development    
      
11 Global Drug Discovery Informatics Market, By End User     
 11.1 Introduction    
 11.2 Academic Institutes    
 11.3 Biotechnology Companies    
 11.4 Contract Research Organization (CROs)    
 11.5 Government Organizations    
 11.6 Hospital    
 11.7 Pharmaceutical Companies    
 11.8 University    
      
12 Global Drug Discovery Informatics Market, By Geography     
 12.1 Introduction    
 12.2 North America    
  12.2.1 US   
  12.2.2 Canada   
  12.2.3 Mexico   
 12.3 Europe    
  12.3.1 Germany   
  12.3.2 UK   
  12.3.3 Italy   
  12.3.4 France   
  12.3.5 Spain   
  12.3.6 Rest of Europe   
 12.4 Asia Pacific    
  12.4.1 Japan   
  12.4.2 China    
  12.4.3 India   
  12.4.4 Australia   
  12.4.5 New Zealand   
  12.4.6 South Korea   
  12.4.7 Rest of Asia Pacific   
 12.5 South America    
  12.5.1 Argentina   
  12.5.2 Brazil   
  12.5.3 Chile   
  12.5.4 Rest of South America   
 12.6 Middle East & Africa    
  12.6.1 Saudi Arabia   
  12.6.2 UAE   
  12.6.3 Qatar   
  12.6.4 South Africa   
  12.6.5 Rest of Middle East & Africa   
      
13 Key Developments     
 13.1 Agreements, Partnerships, Collaborations and Joint Ventures     
 13.2 Acquisitions & Mergers    
 13.3 New Product Launch    
 13.4 Expansions    
 13.5 Other Key Strategies    
      
14 Company Profiling     
 14.1 Albany Molecular Research Inc.    
 14.2 Certara, L.P.    
 14.3 Charles River, Selvita     
 14.4 Collaborative Drug Discovery, Inc    
 14.5 Dassault Systèmes    
 14.6 GVK Biosciences Private Limited    
 14.7 IBM Corporation    
 14.8 Infosys Limited    
 14.9 Insilico Medicine    
 14.10 IO Informatics, Inc.    
 14.11 Jubilant Life Sciences Ltd.    
 14.12 OpenEye Scientific Software    
 14.13 PerkinElmer Inc.    
 14.14 Schrödinger, LLC    
 14.15 Thermo Fisher Scientific    


List of Tables      
1 Global Drug Discovery Informatics Market Outlook, By Region (2019-2028) (US $MN)      
2 Global Drug Discovery Informatics Market Outlook, By Type (2019-2028) (US $MN)      
3 Global Drug Discovery Informatics Market Outlook, By In-House (2019-2028) (US $MN)      
4 Global Drug Discovery Informatics Market Outlook, By Outsourced (2019-2028) (US $MN)      
5 Global Drug Discovery Informatics Market Outlook, By Solution (2019-2028) (US $MN)      
6 Global Drug Discovery Informatics Market Outlook, By Software (2019-2028) (US $MN)      
7 Global Drug Discovery Informatics Market Outlook, By Services (2019-2028) (US $MN)      
8 Global Drug Discovery Informatics Market Outlook, By Function (2019-2028) (US $MN)      
9 Global Drug Discovery Informatics Market Outlook, By Clinical Trial Data Management (2019-2028) (US $MN)       
10 Global Drug Discovery Informatics Market Outlook, By Docking (2019-2028) (US $MN)      
11 Global Drug Discovery Informatics Market Outlook, By Library & Database Preparation (2019-2028) (US $MN)      
12 Global Drug Discovery Informatics Market Outlook, By Molecular Modelling (2019-2028) (US $MN)      
13 Global Drug Discovery Informatics Market Outlook, By Screening & Absorption, Distribution, Metabolism, Excretion and Toxicity (ADMET) Characterization (2019-2028) (US $MN)      
14 Global Drug Discovery Informatics Market Outlook, By Sequencing and Target Data Analysis (2019-2028) (US $MN)      
15 Global Drug Discovery Informatics Market Outlook, By Informatics Workflow (2019-2028) (US $MN)      
16 Global Drug Discovery Informatics Market Outlook, By Discovery Informatics (2019-2028) (US $MN)      
17 Global Drug Discovery Informatics Market Outlook, By Identification, Validation, & Assay Development Informatics (2019-2028) (US $MN)      
18 Global Drug Discovery Informatics Market Outlook, By Lead Generation & Validation (2019-2028) (US $MN)      
19 Global Drug Discovery Informatics Market Outlook, By Development Informatics (2019-2028) (US $MN)      
20 Global Drug Discovery Informatics Market Outlook, By Lead Optimization (2019-2028) (US $MN)      
21 Global Drug Discovery Informatics Market Outlook, By First Human Dose (FHD) Preparation (2019-2028) (US $MN)      
22 Global Drug Discovery Informatics Market Outlook, By Phase IA Informatics (2019-2028) (US $MN)      
23 Global Drug Discovery Informatics Market Outlook, By Phase IB/2 Informatics (2019-2028) (US $MN)      
24 Global Drug Discovery Informatics Market Outlook, By Modality (2019-2028) (US $MN)      
25 Global Drug Discovery Informatics Market Outlook, By Cloud Based Systems (2019-2028) (US $MN)      
26 Global Drug Discovery Informatics Market Outlook, By In Campus Platform (2019-2028) (US $MN)      
27 Global Drug Discovery Informatics Market Outlook, By Application (2019-2028) (US $MN)      
28 Global Drug Discovery Informatics Market Outlook, By Drug Discovery (2019-2028) (US $MN)      
29 Global Drug Discovery Informatics Market Outlook, By Preclinical Testing (2019-2028) (US $MN)      
30 Global Drug Discovery Informatics Market Outlook, By Clinical Trials (2019-2028) (US $MN)      
31 Global Drug Discovery Informatics Market Outlook, By Drug Development (2019-2028) (US $MN)      
32 Global Drug Discovery Informatics Market Outlook, By End User (2019-2028) (US $MN)      
33 Global Drug Discovery Informatics Market Outlook, By Academic Institutes (2019-2028) (US $MN)      
34 Global Drug Discovery Informatics Market Outlook, By Biotechnology Companies (2019-2028) (US $MN)      
35 Global Drug Discovery Informatics Market Outlook, By Contract Research Organization (CROs) (2019-2028) (US $MN)      
36 Global Drug Discovery Informatics Market Outlook, By Government Organizations (2019-2028) (US $MN)      
37 Global Drug Discovery Informatics Market Outlook, By Hospital (2019-2028) (US $MN)      
38 Global Drug Discovery Informatics Market Outlook, By Pharmaceutical Companies (2019-2028) (US $MN)      
39 Global Drug Discovery Informatics Market Outlook, By University (2019-2028) (US $MN)      
      
Note: Tables for North America, Europe, Asia Pacific, South America and Middle East & Africa are represented in the same manner as above.      

List of Figures

RESEARCH METHODOLOGY


Research Methodology

We at Stratistics opt for an extensive research approach which involves data mining, data validation, and data analysis. The various research sources include in-house repository, secondary research, competitor’s sources, social media research, client internal data, and primary research.

Our team of analysts prefers the most reliable and authenticated data sources in order to perform the comprehensive literature search. With access to most of the authenticated data bases our team highly considers the best mix of information through various sources to obtain extensive and accurate analysis.

Each report takes an average time of a month and a team of 4 industry analysts. The time may vary depending on the scope and data availability of the desired market report. The various parameters used in the market assessment are standardized in order to enhance the data accuracy.

Data Mining

The data is collected from several authenticated, reliable, paid and unpaid sources and is filtered depending on the scope & objective of the research. Our reports repository acts as an added advantage in this procedure. Data gathering from the raw material suppliers, distributors and the manufacturers is performed on a regular basis, this helps in the comprehensive understanding of the products value chain. Apart from the above mentioned sources the data is also collected from the industry consultants to ensure the objective of the study is in the right direction.

Market trends such as technological advancements, regulatory affairs, market dynamics (Drivers, Restraints, Opportunities and Challenges) are obtained from scientific journals, market related national & international associations and organizations.

Data Analysis

From the data that is collected depending on the scope & objective of the research the data is subjected for the analysis. The critical steps that we follow for the data analysis include:

  • Product Lifecycle Analysis
  • Competitor analysis
  • Risk analysis
  • Porters Analysis
  • PESTEL Analysis
  • SWOT Analysis

The data engineering is performed by the core industry experts considering both the Marketing Mix Modeling and the Demand Forecasting. The marketing mix modeling makes use of multiple-regression techniques to predict the optimal mix of marketing variables. Regression factor is based on a number of variables and how they relate to an outcome such as sales or profits.


Data Validation

The data validation is performed by the exhaustive primary research from the expert interviews. This includes telephonic interviews, focus groups, face to face interviews, and questionnaires to validate our research from all aspects. The industry experts we approach come from the leading firms, involved in the supply chain ranging from the suppliers, distributors to the manufacturers and consumers so as to ensure an unbiased analysis.

We are in touch with more than 15,000 industry experts with the right mix of consultants, CEO's, presidents, vice presidents, managers, experts from both supply side and demand side, executives and so on.

The data validation involves the primary research from the industry experts belonging to:

  • Leading Companies
  • Suppliers & Distributors
  • Manufacturers
  • Consumers
  • Industry/Strategic Consultants

Apart from the data validation the primary research also helps in performing the fill gap research, i.e. providing solutions for the unmet needs of the research which helps in enhancing the reports quality.


For more details about research methodology, kindly write to us at info@strategymrc.com

Frequently Asked Questions

In case of any queries regarding this report, you can contact the customer service by filing the “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929

Yes, the samples are available for all the published reports. You can request them by filling the “Request Sample” option available in this page.

Yes, you can request a sample with your specific requirements. All the customized samples will be provided as per the requirement with the real data masked.

All our reports are available in Digital PDF format. In case if you require them in any other formats, such as PPT, Excel etc you can submit a request through “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929

We offer a free 15% customization with every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.

We have 3 different licensing options available in electronic format.

  • Single User Licence: Allows one person, typically the buyer, to have access to the ordered product. The ordered product cannot be distributed to anyone else.
  • 2-5 User Licence: Allows the ordered product to be shared among a maximum of 5 people within your organisation.
  • Corporate License: Allows the product to be shared among all employees of your organisation regardless of their geographical location.

All our reports are typically be emailed to you as an attachment.

To order any available report you need to register on our website. The payment can be made either through CCAvenue or PayPal payments gateways which accept all international cards.

We extend our support to 6 months post sale. A post sale customization is also provided to cover your unmet needs in the report.

Request Customization

We provide a free 15% customization on every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.

Note: This customization is absolutely free until it falls under the 15% bracket. If your requirement exceeds this a feasibility check will be performed. Post that, a quote will be provided along with the timelines.

WHY CHOOSE US ?

Assured Quality

Assured Quality

Best in class reports with high standard of research integrity

24X7 Research Support

24X7 Research Support

Continuous support to ensure the best customer experience.

Free Customization

Free Customization

Adding more values to your product of interest.

Safe and Secure Access

Safe & Secure Access

Providing a secured environment for all online transactions.

Trusted by 600+ Brands

Trusted by 600+ Brands

Serving the most reputed brands across the world.

Testimonials